by dyadic | Nov 25, 2019 | Press Releases
High G0 Glycosylation Level Driving Program Acceleration JUPITER, FL / ACCESSWIRE / November 25, 2019 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...
